Back to Journals Drug Design, Development and Therapy Volume 20 GLP-1 Receptor Agonists in Neurological Disorders: From Mechanisms to Clinical Translation Received 1 April 2026 Accepted for publication 2 June 2026 Published 12 June 2026 Volume 2026:20 613616 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 4 Editor who approved publication: Professor Anastasios Lymperopoulos Pengpeng Li, Yangyang Gao, Wei Liu Department of Neurosurgery, Xian Aerospace Hospital of Northwest University, Xian, Shanxi, 710000, Peoples Republic of China Correspondence: Pengpeng Li, Email [email protected] Wei Liu, Email [email protected] Abstract: Glucagon-like peptide-1 receptor agonists, or GLP-1RAs, have been used for years to treat type 2 diabetes and obesity
These medications work by mimicking the effects of the GLP-1 hormone in your body, which helps to regulate blood sugar levels and reduce appetite
Transmission electron microscopy (TEM) measurements were made on a JEM-2100 transmission electron microscope (Jeol Co
Nature (2019) 572(7770):E20
Atendimento das necessidades de micronutrientes em pessoas que esto em processo de emagrecimento associado s canetas emagrecedoras
